RxSight (RXST) Total Non-Current Liabilities (2020 - 2025)
Historic Total Non-Current Liabilities for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $32.6 million.
- RxSight's Total Non-Current Liabilities fell 194.23% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year decrease of 194.23%. This contributed to the annual value of $37.2 million for FY2024, which is 6821.02% up from last year.
- According to the latest figures from Q3 2025, RxSight's Total Non-Current Liabilities is $32.6 million, which was down 194.23% from $31.0 million recorded in Q2 2025.
- Over the past 5 years, RxSight's Total Non-Current Liabilities peaked at $60.3 million during Q4 2022, and registered a low of $19.2 million during Q1 2024.
- Moreover, its 5-year median value for Total Non-Current Liabilities was $33.5 million (2024), whereas its average is $37.0 million.
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 6330.36% in 2023, then soared by 7533.79% in 2025.
- Over the past 5 years, RxSight's Total Non-Current Liabilities (Quarter) stood at $54.5 million in 2021, then rose by 10.62% to $60.3 million in 2022, then tumbled by 63.3% to $22.1 million in 2023, then surged by 68.21% to $37.2 million in 2024, then dropped by 12.46% to $32.6 million in 2025.
- Its Total Non-Current Liabilities stands at $32.6 million for Q3 2025, versus $31.0 million for Q2 2025 and $33.7 million for Q1 2025.